Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hereditary Cancer Syndromes clinical trials
3 of 3 indexed Hereditary Cancer Syndromes trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Hereditary Cancer Syndromes: 3 US clinical trials tracked, 3 recruiting.
Hereditary Cancer Syndromes is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Weill Medical College of Cornell University, running 2 of these trials.
Enrollment posture brief
Registry condition hereditary-cancer-syndromes
OPEN 3 | RECR 100% | LATE 0 | EARLY 0 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Hereditary Cancer Syndromes lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hereditary Cancer Syndromes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hereditary Cancer Syndromes is recruiting above its size-band peers.
3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Weill Medical College of Cornell University
NCT06096688
Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening
Weill Medical College of Cornell University
NCT07052266
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
Nest Genomics
NCT06654466
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Hereditary Cancer Syndromes records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hereditary Cancer Syndromes trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hereditary Cancer Syndromes page
3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Hereditary Cancer Syndromes trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Weill Medical College of Cornell University sponsors the most Hereditary Cancer Syndromes trials on record, review their full trial history before evaluating a specific study. See Weill Medical College of Cornell University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hereditary Cancer Syndromes condition card totals 3 registered trials; most-linked intervention Nest, an electronic medical record (EMR)-integrated software platform to deliver longitudinal, genetics-based care at scale.; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.